[Reproductive and developmental toxicity studies on cefepime dihydrochloride administered subcutaneously to rats during the premating, gestation and lactation periods]. 1992

S Kai, and H Kohmura, and K Ishikawa, and S Kawano, and A Sakai, and K Kuroyanagi, and T Kadota, and N Takahashi
Preclinical Research Laboratories, Bristol-Myers Squibb K. K.

Cefepime dihydrochloride (CFPM) was administered subcutaneously daily at doses of 0, 150, 500 and 1,000 mg/kg for 63 days prior to mating and during mating to male Crj: CD (SD) rats and for 14 days prior to mating and during mating, as well as periods of gestation and lactation to female SD rats. Saline and L-arginine hydrochloride (L-arginine) were used as control articles. Daily doses of test and control articles were equally divided and administered twice a day (b.i.d.). The results obtained are summarized as follows: 1. Soft stool was observed for both male and female F0 rats at CFPM 1,000 mg/kg at the first week of administration period. Further, depilation of injection sites was found in 7 males and 12 females at the same dose level. 2. Body weight gains were suppressed in male F0 rats from Day 28 to 63 of administration period at CFPM 1,000 mg/kg. Moreover, food consumption was reduced in F0 female rats during the first week of administration period at all dose levels of CFPM. 3. CFPM failed to affect the reproductive performance in both male and female F0 rats. 4. Kidney weights were increased in both male and female F0 rats and adrenal weights were augmented in male F0 rats at CFPM 1,000 mg/kg. On the other hand, cecal enlargement were observed for F0 dams treated with CFPM. However, these changes were not considered to be unique to this drug, because they have been described with most antibiotics in this species and appears to be results of modifications in gut flora. 5. Prenatal developments in F1 fetuses were not affected by CFPM. 6. CFPM failed to affect delivery status of F0 dams or survival and lactation indices in F1 pups. 7. CFPM did not affect postnatal differentiations, developmental behaviors, learning ability and memory, spontaneous motor activity or emotionality in F1 rats. 8. Body weight gains and food consumption in both male and female F1 rats were not affected by CFPM. 9. CFPM did not alter the organ weights in both male and female F1 rats. 10. There were no significant differences between drug treated animals and controls regarding the reproductive performance and delivery status of F1 rats. 11. Influences on survival indices, body weights and organ weights were not apparently observed for F2 pups even at CFPM 1,000 mg/kg. Based on the reproductive and developmental indices, the no-effect dose level of CFPM under the present experimental condition was estimated to be 1,000 mg/kg/day against dams (F0) and their offspring (F1).

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D007774 Lactation The processes of milk secretion by the maternal MAMMARY GLANDS after PARTURITION. The proliferation of the mammary glandular tissue, milk synthesis, and milk expulsion or let down are regulated by the interactions of several hormones including ESTRADIOL; PROGESTERONE; PROLACTIN; and OXYTOCIN. Lactation, Prolonged,Milk Secretion,Lactations, Prolonged,Milk Secretions,Prolonged Lactation,Prolonged Lactations
D008297 Male Males
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011270 Pregnancy, Animal The process of bearing developing young (EMBRYOS or FETUSES) in utero in non-human mammals, beginning from FERTILIZATION to BIRTH. Animal Pregnancies,Animal Pregnancy,Pregnancies, Animal
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D005260 Female Females
D005306 Fertilization The fusion of a spermatozoon (SPERMATOZOA) with an OVUM thus resulting in the formation of a ZYGOTE. Conception,Fertilization, Delayed,Fertilization, Polyspermic,Conceptions,Delayed Fertilization,Delayed Fertilizations,Fertilizations,Fertilizations, Delayed,Fertilizations, Polyspermic,Polyspermic Fertilization,Polyspermic Fertilizations
D005314 Embryonic and Fetal Development Morphological and physiological development of EMBRYOS or FETUSES. Embryo and Fetal Development,Prenatal Programming,Programming, Prenatal
D000077723 Cefepime A fourth-generation cephalosporin antibacterial agent that is used in the treatment of infections, including those of the abdomen, urinary tract, respiratory tract, and skin. It is effective against PSEUDOMONAS AERUGINOSA and may also be used in the empiric treatment of FEBRILE NEUTROPENIA. Axépim,BMY 28142,BMY-28142,Cefepim,Cefepime Hydrochloride,Maxipime,Quadrocef,BMY28142

Related Publications

S Kai, and H Kohmura, and K Ishikawa, and S Kawano, and A Sakai, and K Kuroyanagi, and T Kadota, and N Takahashi
May 2001, The Journal of toxicological sciences,
S Kai, and H Kohmura, and K Ishikawa, and S Kawano, and A Sakai, and K Kuroyanagi, and T Kadota, and N Takahashi
April 2003, The Journal of urology,
S Kai, and H Kohmura, and K Ishikawa, and S Kawano, and A Sakai, and K Kuroyanagi, and T Kadota, and N Takahashi
November 1992, The Journal of toxicological sciences,
S Kai, and H Kohmura, and K Ishikawa, and S Kawano, and A Sakai, and K Kuroyanagi, and T Kadota, and N Takahashi
March 2007, Journal of preventive medicine and public health = Yebang Uihakhoe chi,
S Kai, and H Kohmura, and K Ishikawa, and S Kawano, and A Sakai, and K Kuroyanagi, and T Kadota, and N Takahashi
January 2004, Wei sheng yan jiu = Journal of hygiene research,
S Kai, and H Kohmura, and K Ishikawa, and S Kawano, and A Sakai, and K Kuroyanagi, and T Kadota, and N Takahashi
June 1990, The Journal of toxicological sciences,
S Kai, and H Kohmura, and K Ishikawa, and S Kawano, and A Sakai, and K Kuroyanagi, and T Kadota, and N Takahashi
October 1993, Teratology,
S Kai, and H Kohmura, and K Ishikawa, and S Kawano, and A Sakai, and K Kuroyanagi, and T Kadota, and N Takahashi
June 1975, Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles,
S Kai, and H Kohmura, and K Ishikawa, and S Kawano, and A Sakai, and K Kuroyanagi, and T Kadota, and N Takahashi
April 2009, Birth defects research. Part B, Developmental and reproductive toxicology,
S Kai, and H Kohmura, and K Ishikawa, and S Kawano, and A Sakai, and K Kuroyanagi, and T Kadota, and N Takahashi
November 1998, The Japanese journal of antibiotics,
Copied contents to your clipboard!